All News
Dr Ross Wilkie won one of the Best Abstract Awards at the European Congress of Rheumatology #EULAR2019. His study identified targets for reducing premature death in older people with #osteoarthritis. Great research led by health professionals. #HPR https://t.co/RZ2salIn3M https://t.co/huAilBKUCG
Links:
Mwidimi Ndosi ndosie ( View Tweet)
Co-founder and Director of dotMD Dr Ronan Kavanagh explains what was involved in choosing speakers for this year’s conference https://t.co/FFiqxje4HF @DotMDConf @RonanTKavanagh
Links:
Medical Independent med_indonews ( View Tweet)
Minimal Disease Activity in PsA is more challenging in women than in men. Unpublished data from the TICOPA trial presented by Dr. Laura Coates. #PsA #EULAR2019
Xabier Michelena Vegas xabiermich ( View Tweet)
What factors are linked with fatigue in women in the first year of #RA? One #EULAR2019 study found these 4: obesity, steroid use, seronegativity, and poor sleep https://t.co/40lyEXjE2U
CreakyJoints.org CreakyJoints ( View Tweet)
New anti-CD20 Mab Obinutuzumab just delivered positive results in its phase 2 study in lupus nephritis. We need to know more! #EULAR2019 https://t.co/Bx9OdmEtpy
Alberta Hoi tuna0sashimi ( View Tweet)
Hydroxychloroquine: proposed risk factors for Retinopathy #EULAR2019 https://t.co/WkyNZ4GPVr
Dr Irwin Lim _connectedcare ( View Tweet)
Mease: SEAM study MTX vs Etanercept in PsA.
ETA effects > MTX with no additional benefit of combination.
But some MTX benefit (note no PBO arm).
Interesting separation between MTX<ETA for PASDAS (muli domain) but not DAPSA (joints only) #Eular2019 @RheumNow https://t.co/WSUlGE7NEf
Stefan Siebert StefanSiebert1 ( View Tweet)
#Gout patients tend not to tell doctors impact of gout on quality of life
👉🏼43% #mentalhealth
👉🏼27% impact on family
👉🏼26% relationship with partners
➡️🔟% lost job or retired due to gout
by Meulemeester #EULAR2019 https://t.co/fyrAyvpaYO
Dr Ai Lyn Tan DrAiLynTan ( View Tweet)
Mease: Filgotinib (selective JAK1i) in active PsA ph2. Promising data.
Interesting and informative way to present individual participant level data over time rather than just aggregate data - may be more useful for clinicians and patients to understand.
#EULAR2019 @RheumNow https://t.co/B0pLODWGJ9
Stefan Siebert StefanSiebert1 ( View Tweet)
So, what are we left with? Some patients get another year free of remission - that’s good. TCZ is steroid-sparing - that’s good. Still questions about longer follow-up and sequelae, and a year’s therapy doesn’t cure everyone. It’s not a panacea for all GCA ills, but it’s a start! https://t.co/6AiIQLnLFN
David Liew drdavidliew ( View Tweet)
Well it’s not all she wrote when flares come along, flares can be treated - some data on how to fix them, but beware the channeling bias https://t.co/o0rwYr1Ll7
David Liew drdavidliew ( View Tweet)
McInnes: Machine-learning separates out 13 clusters of PsA in RCT population (i.e. already selected).
Offers opportunities to reduce some of the massive heterogeneity in PsA to help inform biomarker studies and future precision medicine strategies. #Eular2019 @RheumNow https://t.co/h3Otp4Oq8U
Stefan Siebert StefanSiebert1 ( View Tweet)
For new knee inflammatory arthritis nearly 60% are in full remission at one year whereas 10% spread to progressive arthritis and 30% have persistent knee IA. Leiden Early arthritis cohort #EULAR2019 @RheumNow https://t.co/ZuLI1OCfhT https://t.co/x2Tr1tF0j6
Janet Pope Janetbirdope ( View Tweet)
Poster THU0687 FMF and schizo each increase mortality and worse if co-occurrence #EULAR2019 @RheumNow https://t.co/nVfiw25Lzf https://t.co/U9KELLJzVD
Janet Pope Janetbirdope ( View Tweet)
Be sure not to miss our symposium tomorrow morning: ‘The Patient Perspective: Addressing Challenges Facing Women with #axSpA and PsA’. Join us tomorrow! #EULAR2019 #psoriaticarthritis https://t.co/G0NkmblAhI
UCB News ucb_news ( View Tweet)
Checkpoint inhibitor use is exploding in cancer Rx. Big data review of 13000 cases of immune mediated reactions are mostly endo, GI and pulmonary and NOT rheumatic THUS0628 #EULAR2019 @RheumNow https://t.co/iYO8t6ALBx
Janet Pope Janetbirdope ( View Tweet)
Olofsson, Sweden: important topic of unacceptable residual pain despite biologic in PsA with >80% of this pain despite good inflammatory control
#Eular2019 @RheumNow https://t.co/vjiakjCKR0
Stefan Siebert StefanSiebert1 ( View Tweet)
What happens to momo or bilateral knee synovitis in 12 months? #EULAR2019 @RheumNow THU0674
Janet Pope Janetbirdope ( View Tweet)
Strange lack of association Schizophrenia is decreased in Familial Med fever (FMF). HLA B08 is protective against schizo in RA. They speculate that pure autoimmune diseases have more schizo and auto inflammatory less schizo #EULAR2019 @RheumNow
Janet Pope Janetbirdope ( View Tweet)
Great clinical advice from @MarieKostine in today's EULAR recommendations on rheumatic irAEs from cancer immunotherapy, but most of all, oncologists should be encouraged to refer promptly and rheumatologists need to make themselves readily accessible! #EULAR2019 OP0165 @RheumNow
David Liew drdavidliew ( View Tweet)